Freezing gallstone disease in its tracks
The first minimally invasive gallbladder ablation solution that gives patients the benefits of surgery, without the risk.
MEET OUR TEAM
Innovative Team of Industry, Clinical and Business Experts
Born out of the Texas Medical Center (TMC) Biodesign fellowship, Ictero is a team of passionate engineers, scientists, clinicians, and entrepreneurs dedicated to developing innovative medical technology that addresses today’s most pressing clinical needs.
Ictero methodically developed The CholeSafe System to be a commercially viable, definitive, and safe treatment for gallstone disease.
Matthew Nojoomi, MSE
CEO, Co-Founder
David Waters, MD
COO, Co-Founder
Kovi Bessoff, MD, PhD
Clinical Research Lead,
Co-Founder
Raymond Kirk, MD, FACR
CMO
Supporting Partners
